Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome

被引:0
|
作者
A. Wick
N. Schäfer
N. Dörner
D. Schemmer
M. Platten
M. Bendszus
W. Wick
机构
[1] University of Heidelberg,Department of Neurooncology
[2] University of Heidelberg,Department of Neuroradiology
来源
Journal of Neuro-Oncology | 2010年 / 97卷
关键词
Renal Cell Carcinoma; Bevacizumab; Hypertensive Patient; Arterial Hypertension; Brain Tumor Patient;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:157 / 158
页数:1
相关论文
共 50 条
  • [1] Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome
    Wick, A.
    Schaefer, N.
    Doerner, N.
    Schemmer, D.
    Platten, M.
    Bendszus, M.
    Wick, W.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2010, 97 (01) : 157 - 158
  • [2] Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab
    R. A. Manneh Kopp
    J. M. Sepúlveda-Sánchez
    Y. Ruano
    O. Toldos
    A. Pérez Núñez
    D. Cantero
    A. Hilario
    A. Ramos
    G. de Velasco
    P. Sánchez-Gómez
    A. Hernández-Laín
    [J]. Clinical and Translational Oncology, 2019, 21 : 1413 - 1423
  • [3] Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab
    Manneh Kopp, R. A.
    Sepulveda-Sanchez, J. M.
    Ruano, Y.
    Toldos, O.
    Perez Nunez, A.
    Cantero, D.
    Hilario, A.
    Ramos, A.
    de Velasco, G.
    Sanchez-Gomez, P.
    Hernandez-Lain, A.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (10): : 1413 - 1423
  • [4] Bevacizumab-induced hypertension correlation with survival in recurrent glioblastoma multiforme
    Tavares, N. T.
    Simoes, J.
    Borges, C.
    Meireles, S.
    Costa, A.
    Fernandes, C.
    Caeiro, C.
    Damasceno, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [5] Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients
    Carvalho, Bruno
    Lopes, Rafaela Goncalves
    Linhares, Paulo
    Costa, Andreia
    Caeiro, Claudia
    Fernandes, Ana Catarina
    Tavares, Nuno
    Osorio, Ligia
    Vaz, Rui
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (01) : 109 - 116
  • [6] Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients
    Bruno Carvalho
    Rafaela Gonçalves Lopes
    Paulo Linhares
    Andreia Costa
    Cláudia Caeiro
    Ana Catarina Fernandes
    Nuno Tavares
    Lígia Osório
    Rui Vaz
    [J]. Journal of Neuro-Oncology, 2020, 147 : 109 - 116
  • [7] ARTERIAL HYPERTENSION CORRELATES WITH CLINICAL OUTCOME IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST-LINE BEVACIZUMAB
    Scartozzi, M.
    Galizia, E.
    Giampieri, R.
    Chiorrini, S.
    Berardi, R.
    Pierantoni, C.
    Cascinu, S.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 128 - 129
  • [8] Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
    Scartozzi, M.
    Galizia, E.
    Chiorrini, S.
    Giampieri, R.
    Berardi, R.
    Pierantoni, C.
    Cascinu, S.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (02) : 227 - 230
  • [9] Bevacizumab for the treatment of glioblastoma
    Chowdhary, Sajeel
    Chamberlain, Marc
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (08) : 937 - 949
  • [10] Bevacizumab for the Treatment of Glioblastoma
    Gil-Gil, Miguel J.
    Mesia, Carlos
    Rey, Montserrat
    Bruna, Jordi
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 123 - 135